15 results
6-K
EX-99.4
AMYT
Amryt Pharma Plc
12 Apr 23
Current report (foreign)
5:28pm
. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. By changing its legal status
6-K
EX-99.6
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
, our mission is to transform the lives of people affected by rare, debilitating conditions by providing innovative medicines that bring hope to those
20-F
2020 FY
AMYT
Amryt Pharma Plc
30 Apr 21
Annual report (foreign)
12:53pm
facilities and products except for those deemed to be “mission critical.” On March 18, 2020, the FDA announced its intention to temporarily postpone … , while foreign inspections remained limited to those deemed “mission critical.” In March 2021, the U.S. Government Accountability Office issued
424B4
AMYT
Amryt Pharma Plc
14 Jan 21
Prospectus supplement with pricing info
9:30am
capabilities.
Our Strategy
Our mission is to become a global leader in the treatment of rare diseases through commercializing, developing … and acquiring novel rare disease products. To achieve this mission, we are pursuing the following strategies:
Drive revenue growth for our existing commercial
F-1/A
emnu9zeja
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
nsod8m79452q04tqieub
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
yqb6k6uk96utb sl
18 Dec 20
Draft registration statement
12:00am
424B4
irpz2eik2pucuqbn3yo
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
1m3 00kgn4ff
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
F-1
EX-10.12.5
gk0 b68m0vd0xavmm99
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
680fc1l3nt9
23 Jun 20
Registration statement (foreign)
5:21pm
DRS/A
ybvdolql5srkwo996a
29 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.12
5foqdagmld3 8trfsm
11 May 20
Draft registration statement (amended)
12:00am
DRS
tqpmwq2
19 Feb 20
Draft registration statement
12:00am
- Prev
- 1
- Next